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ABSTRACT Felbamate (FBM) is a potent nonsedative anticonvulsant whose clinical effect is chieﬂy related to gating
modiﬁcation (and thus use-dependent inhibition) rather than pore block ofN-methyl-D-aspartate (NMDA) channels at pH7.4.Using
whole-cell recording in rat hippocampal neurons, we examined the effect of extracellular pH onFBMaction. In sharp contrast to the
ﬁndings at pH 7.4, the inhibitory effect of FBM on NMDA currents shows much weakened use-dependence at pH 8.4. Moreover,
FBMneither accelerates theactivation kinetics of theNMDAchannel, nor enhances the currents elicited by very lowconcentrations
of NMDA at pH 8.4. These differential effects of FBM between pH 7.4 and 8.4 are abolished in the mutant NMDA channels which
lack proton sensitivity. Most interestingly, the inhibitory effect of FBM becomes ﬂow-dependent and is evidently stronger in inward
than in outward NMDA currents at pH 8.4. These ﬁndings indicate that FBM has a signiﬁcantly more manifest pore-blocking effect
on the NMDA channel at pH 8.4 than at pH 7.4. FBM therefore acts as an opportunistic pore blocker modulated by extracellular
proton, suggesting that theFBMbinding site is located at the junction of awidened andanarrowpart of the ion conduction pathway.
Also,we ﬁnd that the inhibitory effect of FBMonNMDAcurrents is antagonizedby external but not internalNa1, and that increaseof
external Na1 decreases the binding rate without altering the unbinding rate of FBM. These ﬁndings indicate that the FBM binding
site faces the extracellular rather than the intracellular solution, and coincides with the outmost ionic (e.g., Na1) site in the NMDA
channel pore. We conclude that the FBM binding site very likely is located in the external pore mouth, where extracellular proton,
Na1, FBM, and NMDA channel gating have an orchestrating effect.
INTRODUCTION
N-Methyl-D-aspartate (NMDA) channel antagonists have
been found to show a broad-spectrum antiepileptic effect on
experimental seizure models (1). Although the anticonvul-
sant activity of NMDA channel antagonists has generated
considerable interest, in clinical trials most NMDA channel
antagonists have demonstrated serious neurobehavioral com-
plications that have limited their further pharmaceutical
development (2,3). Up to now, the only approved anticon-
vulsant that exhibits NMDA channel inhibitory activity at
therapeutic concentrations is felbamate (FBM; 2-phenyl-1,3-
propanediol dicarbamate) (4–7). Although side effects such
as aplastic anemia and hepatotoxicity have limited its use as
a ﬁrst-line agent, FBM has remained as a useful anticonvul-
sant for Lennox-Gastaut syndrome in children and for a
variety of complex partial seizures that are refractory to the
other anticonvulsants in adults (for a review, see (8–10)).
We have shown that FBM has a higher afﬁnity to the open
and especially the desensitized NMDA channels (dissocia-
tion constants ;110 and ;55 mM, respectively) than to the
closed channels (dissociation constant ;200 mM) (5). Also,
FBM delays the recovery from desensitization in the NMDA
channel. Although the differences between the binding
afﬁnity is not large, the selective binding of FBM to the open
and especially to the desensitized channels well explains,
both qualitatively and quantitatively, the enhancement of
NMDA currents in low concentrations (#10 mM) of NMDA
and the (use-dependent) inhibition of NMDA currents in
high concentrations ($30 mM) of NMDA (5,11). Submilli-
molar FBM thus is an effective gating modiﬁer rather than a
pore blocker of the NMDA channel at pH 7.4. The gating-
modiﬁcation actions of FBM are similar to ifenprodil (a
phenylethanolamine), which also enhances NMDA currents
when the NMDA concentration is extremely low (e.g., 0.3–
1 mM) but has a dose-dependent inhibitory effect in higher
concentrations of NMDA (12–14). It seems that FBM and
ifenprodil, albeit structurally different, both favor the confor-
mational changes induced by NMDA on NMDA channels,
namely activation and desensitization. It has been shown that
the high-afﬁnity binding site of ifenprodil is located in the
amino terminal domain of NR2B subunit (12,15). Interest-
ingly, FBM also has a stronger effect on NMDA channels
containing NR2B than those containing NR2A or NR2C
subunit (4,16). However, Kleckner et al. found that muta-
tions in the amino terminal of NR2B subunit may signiﬁ-
cantly affect ifenprodil but not FBM binding (4). The molecular
and functional location of the FBM binding site thus remains
largely unclear.
Nanomolar extracellular proton is a well-known gating
modiﬁer of the NMDA channel. The modiﬁcation is so strong
that there could be a tonic inhibition of NMDA currents by
;50% at physiological pH (17–20). Extracellular proton
may also interact with the other gating modiﬁers of the
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channel. For example, the inhibitory effect of ifenprodil on
NMDA currents is strongly dependent on extracellular pro-
ton, and there is a 30-fold increase of the IC50 value with a
change of pH from 8.5 to 7.0 ((21); see also (14)). It would
therefore be interesting to see whether there are also inter-
actions between extracellular proton and FBM, which has a
similar gating-modiﬁcation effect to ifenprodil. In this study,
we demonstrate that in contrast to the case at pH 7.4, FBM
shows evident features of a pore blocker of the NMDA channel
at pH 8.4. Also, the inhibitory effect of FBM on NMDA
currents is antagonized by external but not internal Na1.
FBM thus is an opportunistic pore blocker of the NMDA
channel with its binding site located at a pore region of critical
dimensions, most likely the junction of a widened and a nar-
row part in the external vestibule of the channel pore. These
ﬁndings may indicate extracellular pH-sensitive as well as
functionally important gating conformational changes at this
pore region.
MATERIALS AND METHODS
Dissociated neuron preparation
Coronal slices of the whole brain were prepared from 7- to 14-day-old
Wistar rats. Hippocampal CA1 region was dissected from the slices and cut
into small chunks. Tissue chunks were treated with 1 mg/ml protease XXIII
(Sigma, St. Louis, MO) in dissociation medium (82 mM Na2SO4, 30 mM
K2SO4, 3 mMMgCl2, and 5 mM HEPES, pH 7.4) for 3–5 min at 35C, and
then were moved into dissociation medium containing no protease but
1 mg/ml bovine serum albumin (Sigma). Each time two to three chunks were
picked and triturated to release single neurons for whole-cell recordings.
Whole-cell recordings
The dissociated neurons were put in a recording chamber containing
Tyrode’s solution (150 mM NaCl, 4 mM KCl, 2 mM MgCl2, 2 mM CaCl2,
and 10 mM HEPES, pH 7.4). Whole-cell voltage-clamp recordings were
obtained using ﬁre-polished pipettes pulled from borosilicate capillaries
(outer diameter, 1.55–1.60 mm; Hilgenberg, Malsfeld, Germany). Except
for the internal FBM experiments in Fig. 6 and the experiments of different
concentrations of internal Na1 in Figs. 5 C and 8 B, the pipettes were ﬁlled
with the standard (150 mM Na1) internal solution containing 75 mM NaCl,
75 mM NaF, 10 mM HEPES, and 5 mM EGTA, with pH adjusted to 7.4 by
NaOH. For the experiments studying the effect of internal FBM in Fig. 6,
1 mM FBMwas added to the standard internal solution. In Figs. 5 C and 8 B,
the internal solutions of 300 and 450 mM Na1 contained the same
components as the standard internal solution, except that 75 mM NaCl was
replaced by 225 and 375 mM NaCl, respectively. The internal solution of 75
mM Na1 contained 40 mM NaCl, 35 mM NaF, 10 mM HEPES, and 5 mM
EGTA. A seal was formed, and the whole-cell conﬁguration was obtained in
Tyrode’s solution. The cell was then lifted from the bottom of the chamber
and moved in front of a set of Square glass, three-barrel tubes (0.6 mm
internal diameter) or Theta glass tubes (2.0 mm outer diameter pulled to an
opening of ;300 mm in width; Warner Instrument, Hamden, CT) emitting
either control or FBM-containing external recording solutions. Except for
the experiments of different concentrations of external Na1 in Figs. 5, A and
B, 7, C and D, and 8 A, the standard external solution was Mg21-free
Tyrode’s solution (pH 7.4 or 8.4). In Figs. 5, A and B, 7, C and D, and 8 A,
the external Na1 concentration was changed from 25 to 750 mM with the
same other components as the Mg21-free Tyrode’s solution. Different
amounts of sucrose were added into the solution on the opposite side to
maintain roughly the same osmolarity on both sides of the membrane and
reduce the likelihood of losing a tight seal. All external solutions contained
0.5 mM tetrodotoxin to block the sodium currents. The glass-tube holder was
connected to a stepper motor (SF-77B perfusion system, Warner Instrument)
to achieve fast switch between different tubes and therefore rapid solution
change. The rate of solution change was assessed by the method described
previously (5). In short, the rate of change in current size between two
different external solutions, namely Tyrode’s solution and a solution
containing 150 mM N-methyl-D-glucamine instead of 150 mM Na1. The
50% current change time is ;6 ms and ;40 ms for the Theta glass and
the Square glass, respectively (5). Theta glass tubes were therefore used in
the experiments investigating the effect of FBM on the kinetics of channel
gating in Figs. 2 and 7, where a better resolution in the time domain is
required. In the other experiments, Square glass tubes were used because a
larger number of different kinds of external solutions can be loaded at the
same time. FBM (Tocris Cookson, Bristol, UK) was dissolved in dimethyl
sulfoxide as well as NMDA and glycine (Sigma) were dissolved in water to
make 100, 100, and 10 mM stock solutions, respectively. The stock
solutions were then diluted into Mg21-free Tyrode’s solution to attain the
ﬁnal concentrations desired (10 mM to 1 mM FBM, 6 mM or 1 mM NMDA,
0.3 mM glycine). The ﬁnal concentration of dimethyl sulfoxide (#1%) was
found to have no detectable effect on NMDA currents. The highest FBM
concentration used in this study was;3 mM, which is roughly the maximal
solubility of the drug in water, and was made by dissolving FBM directly
into Mg21-free Tyrode’s solution right before the experiment. However, 300
mM was chosen as the most used FBM concentration in this study, because
300 mM is well within the solubility limit and also the therapeutic range
(50–300mM) of the drug. The cells were voltage-clamped at70 mV unless
otherwise speciﬁed. NMDA currents were recorded at room temperature
(;25C) with an Axoclamp 200A ampliﬁer, ﬁltered at 1 kHz with a four-
pole Bessel ﬁlter, digitized at 200- to 500-ms intervals, and stored using a
Digidata-1322A analog/digital interface along with the pCLAMP software
(all from Axon Instruments, Union City, CA). Data are expressed as mean6
SE. For comparisons between experimental groups, the Student’s t-test was
used and p , 0.05 was considered to be statistically signiﬁcant.
Molecular biology
The rat cDNA clones of NMDA channels used in this study are the NR1a
variant and the NR2B clone. The sequences of amino acid residues in the
NR1 subunit are numbered from the initiator methionine as in the original
article (22). Site-directed mutagenesis in the NR1 subunit was carried out
using the QuikChange kit (Stratagene, La Jolla, CA). Mutations were
veriﬁed by DNA sequencing, and two independent clones for each mutant
were tested to preclude any inadvertent mutations. The full-length capped
cRNA transcripts were then synthesized from each of NR1 and NR2B using
T7 and T3 mMESSAGE mMACHINE transcription kits (Ambion, Austin,
TX), respectively. Xenopus oocytes (stages V–VI) were injected with a
mixture of NR1 and NR2 cRNAs in a ratio of 1:5 to minimize the probability
of formation of homomeric NR1 receptors. Oocytes were then maintained in
the culture medium (96 mM NaCl, 2 mM KCl, 1.8 mM MgCl2, 1.8 mM
CaCl2, 5 mM HEPES, and 50 mg/ml gentamycin, pH 7.6) at 18C for 2–3
days before intracellular recordings.
Intracellular recordings
Oocytes were placed in a small working-volume (,20 ml) perfusion
chamber (OPC-1, AutoMate Scientiﬁc, San Francisco, CA) that is optimized
for fast solution exchange. The NMDA currents were recorded at room
temperature (;25C) with two-electrode voltage clamp (OC-725C ampli-
ﬁer; Warner Instrument). The microelectrodes, pulled from borosilicate
capillaries and ﬁlled with 1 M KCl, had resistances of 0.5–4 MV. Oocytes
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were voltage-clamped at 70 mV and continuously perfused with Mg21-free
ND 96 solution (96 mM NaCl, 2 mM KCl, 0.3 mM BaCl2, and 5 mM
HEPES, pH 7.4 or 8.4). Data were acquired using the Digidata-1322A
analog/digital interface with pCLAMP software (Axon Instruments). The
sampling rates were 0.5–1 kHz, and all statistics are given as mean 6 SE.
RESULTS
FBM may act as a pore blocker of the NMDA
channel at extracellular pH 8.4
Fig. 1, A and B, shows that FBM has only little inhibitory
effect on the early peak NMDA current but signiﬁcantly
inhibits the late sustained current at pH 7.4 and 6.4. In these
conditions, the inhibitory effect of FBM on NMDA currents
is stronger with longer exposure to NMDA, a feature in-
dicative of use-dependent inhibition (see also (5)). In con-
trast, FBM signiﬁcantly inhibits both the early peak and late
sustained NMDA currents at pH 8.4, suggesting loss of use-
dependence of FBM action at more alkaline external milieu.
On the other hand, the desensitization kinetics of the channel
seems to get slower when extracellular pH becomes more
alkaline whether FBM is present or not (Fig. 1, A and C),
consistent with the idea that the external proton itself could
effectively modulate NMDA channel gating. In this case
FBM still signiﬁcantly accelerates the desensitization pro-
cess at pH 7.4 and 6.4, but much less so at pH 8.4. The effect
of FBM on desensitization thus is also pH-dependent. Fig.
1 D further shows that loss of use-dependence is most likely
ascribable to the much stronger inhibitory effect of FBM on
the peak currents at pH 8.4 than at pH 7.4 in the presence of
100 mM to 3 mM FBM. On the other hand, extracellular
proton has only negligible effect on the IC50 value for FBM
inhibition of the sustained (steady-state) NMDA currents
(IC50 ¼ 0.71 and 0.64 mM at pH 7.4 and 8.4, respectively,
Fig. 1 E). We then explored the effect of FBM on the acti-
vation kinetics of the NMDA channel at different extracel-
lular pH in more detail (Fig. 2). At pH 7.4 and 6.4, FBM
evidently enhances rather than inhibits the NMDA currents
elicited by very low concentrations (e.g., 6 mM) of NMDA
and signiﬁcantly accelerates the rising phase of NMDA
FIGURE 1 The inhibitory effect of FBM on NMDA
currents shows much weakened use-dependence at pH 8.4.
(A) NMDA currents were elicited by application of 1 mM
NMDA and 0.3 mM glycine in the absence (control) and
presence of 300 mM FBM at different extracellular pH. If
FBM was present in the external solution, it was present
throughout the whole experiment (i.e., before, during, and
after the NMDA pulse). FBM has only little inhibitory
effect on the early peak current, but signiﬁcantly inhibits
the late sustained current at pH 7.4 (left panel). In contrast,
FBM signiﬁcantly inhibits both the early peak and late
sustained currents at pH 8.4 (right panel). (B) Cumulative
results are obtained from eight cells with the same ex-
perimental protocol described in panel A. The relative
current is deﬁned by the ratio between the amplitude of the
currents elicited by the 1 mM NMDA pulse in FBM-
containing and FBM-free external solutions in the same
cell. For the peak currents, the relative currents are 0.95 6
0.03, 0.93 6 0.01, and 0.76 6 0.02 for pH 6.4, 7.4, and
8.4, respectively. For the late currents, the relative currents
are 0.786 0.03, 0.756 0.02, and 0.706 0.02 for pH 6.4,
7.4, and 8.4, respectively. (C) The experimental protocol is
similar to that described in panel A. The decay phase of the
macroscopic NMDA currents is ﬁtted with a single-
exponential function, and the inverse of the time constant
from the ﬁt is deﬁned as the desensitization rate (n ¼ 8).
*p, 0.05, compared with the control data at pH 7.4. #p,
0.05, compared with the control data at the same pH value.
(D and E) The same experiment as that described in panel
A was repeated in different concentrations of FBM (10 mM
to 3 mM). The cumulative results of the relative current are
plotted against the FBM concentration (n ¼ 5). For the
peak current, it is evident that the data at pH 8.4 are
signiﬁcantly smaller than those at pH 7.4 in 100 mM to
3 mM FBM (*p, 0.05) (D). For the sustained current, the
two solid lines are the best ﬁts to the mean data of pH 7.4
and 8.4 using the Hill equation (response ¼ maximal
response/(11([FBM]/IC50)
nH), where nH is the Hill coef-
ﬁcient). The best ﬁts give calculated IC50 values of 0.71
and 0.64 mM FBM at pH 7.4 and 8.4, respectively (E).
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currents, well consistent with the proposal that FBM is a
gating modiﬁer but not a pore blocker in these conditions (5).
In sharp contrast, at pH 8.4 FBM neither enhances the small
currents elicited by 6 mM NMDA (Fig. 2 C), nor accelerates
the activation kinetics of the NMDA channel (Fig. 2 D).
These ﬁndings, along with the much weakened use-depen-
dence of FBM inhibition on NMDA currents (i.e., the much
stronger inhibition of the peak NMDA current by FBM) at
pH 8.4 (Fig. 1), strongly suggest that FBM has a signiﬁcantly
different mode of action on the NMDA channel with the
;1 pH unit change. Unlike the cases at pH 7.4 and 6.4, FBM
seems to have an additional mechanism of channel inhibi-
tion, such as pore block, at pH 8.4.
The differential effects of FBM between pH 7.4
and 8.4 are abolished in the mutant channels
which are insensitive to extracellular proton
To conﬁrm that the differential effects of FBM on NMDA
currents between pH 7.4 and 8.4 are indeed dependent on
extracellular pH, we investigated the FBM effects on the
current elicited by 6 mM NMDA at pH 7.4 and 8.4 in the
wild-type (NR1-2B) and NR1 mutant NMDA channels.
Thirteen consecutive (Y647-R659) point mutations in the
M3c and postM3 domains which both are reported to be
critically related to proton sensitivity of the NMDA channel
(23) were examined. Fig. 3 shows that FBM enhances the
small current at pH 7.4 but not at pH 8.4 in the wild-type
channel (132 6 3% vs. 98 6 2%, n ¼ 6, p , 0.05), very
similar to the ﬁndings from the dissociated neurons in Fig. 2.
Although all 13 NR1 mutations generated functional chan-
nels, we found that 6 mutations no longer show signiﬁcant
differential effects of FBM on the NMDA current between
pH 7.4 and 8.4. Most interestingly, these six residues (i.e.,
T648, A649, A653, V656, L657, and R659 in NR1) exactly
coincide with the positions which are reported to be the
probable proton sensor sites (23). These results further
support that the subtle but signiﬁcant difference of FBM
effects between pH 7.4 and 8.4 is indeed modulated by ex-
tracellular proton. Because the protonation status of the side
chains of the foregoing six residues are unlikely to be changed
between pH 7.4 and 8.4, and most importantly because the
six residues exactly coincide the previously reported proton-
modulation sites of NMDA channel gating even in the
absence of FBM, the interaction between external proton and
FBM is most likely achieved indirectly or allosterically via
their individual effects on NMDA channel conformations
and functions.
FIGURE 2 FBM fails to accelerate the activation kinet-
ics of NMDA currents at pH 8.4. (A) The cell was moved
every 60 s from the NMDA- and glycine-free external
solution to the external solution containing 6 mM NMDA
and 0.3 mM glycine for 1 s, and then moved back to the
NMDA-free external solution. FBM either was absent in
both external solutions (the control sweep), or 300 mM
FBM was added only to the NMDA-free but not the
NMDA-containing external solutions (the 300 mM FBM
sweep). The early NMDA current is evidently enhanced
with the rising phase accelerated by FBM at pH 7.4, but
FBM has only a negligible effect on the NMDA current at
pH 8.4. (B) The rising phase of the currents in panel A is
enlarged to demonstrate the accelerated channel activation
in detail. The arrow indicates the time point at which the
command of solution change is given electronically. The
current between 35 and 45 ms from the arrow is ﬁtted with
a linear regression function to obtain the slope of current
increase (in the unit of pA/ms). This time window is a
deliberately chosen compromise, because it should be as
late as possible to avoid incomplete solution change and
the probable initial delay in channel activation (solution
change should be complete within 30 ms of the electronic
command with Theta glass tube, see Materials and
Methods and (5)) but as early as possible to avoid
contamination of channel desensitization. (C,D) Cumula-
tive results are obtained from ﬁve cells with the same
experimental protocol described in panels A and B. The
relative early current is deﬁned by the ratio between the
amplitude of the currents (the average current from 100 to
150 ms after the beginning of the NMDA pulse) elicited by 6 mM NMDA pulse in the presence and absence of 300 mM FBM in the same cell. The relative
currents are 1.436 0.09, 1.356 0.04, and 0.996 0.02 for pH 6.4, 7.4, and 8.4, respectively (C). In each individual cell, the slope of current increase with 300
mM FBM is normalized to the slope in the control (FBM-free) condition to give the relative activation speed. The cumulative results of the relative activation
speed from ﬁve cells are 1.68 6 0.06, 1.47 6 0.03, and 1.02 6 0.05 for pH 6.4, 7.4, and 8.4, respectively (D). *p , 0.05, compared with the data at pH 7.4.
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The inhibitory effect of FBM on NMDA currents
is ﬂow-dependent at pH 8.4 but not at pH 7.4
We further examined the possibility if FBM indeed becomes
an effective NMDA channel pore blocker at pH 8.4. Fig. 4,
A–C, shows that at pH 8.4 FBM signiﬁcantly inhibits the
peak NMDA currents at all negative holding potentials from
70 to 10 mV (i.e., when there are inward currents or the
preponderant direction of current ﬂow is inward). By con-
trast, the inhibitory effect of FBM is evidently smaller at all
positive holding potentials from 110 to 170 mV (i.e.,
outward currents). However, comparison between the in-
hibitory effects at70 and at30 mV (or at170 and at130
mV) does not show voltage-dependence. The inhibitory
effects remain similar if the direction of current ﬂow remains
the same (Fig. 4, B and C). These ﬁndings show that at pH
8.4 the inhibitory effect of FBM on NMDA currents is ﬂow
(direction)-dependent but not voltage-dependent, and is
signiﬁcantly stronger in inward than in outward currents.
The ﬂow-dependent blocking phenomenon could be ob-
served in the other instances, and is always a strong evidence
arguing that the inhibitor binds to the channel pore. For
example, in the inward rectiﬁer potassium channel the out-
ward current is signiﬁcantly inhibited by intrinsic intracel-
lular pore blockers Mg21 and polyamines, but the inward
current is not (24–27). Although many NMDA channel pore
blockers (e.g., Mg21 and MK-801) do show voltage depen-
dence of inhibition, these compounds are charged at physio-
logical pH. FBM is a dicarbamate and is not signiﬁcantly
charged (protonated) at physiological or more alkaline pH
(e.g., pH 8.4). The lack of voltage dependence of FBM
inhibition on NMDA currents therefore is actually an ex-
pected rather than unexpected ﬁnding even for a FBM
binding site in the pore, further substantiating that the dif-
ferential inhibitory effects between130;170 mV and30
; 70 mV at pH 8.4 should be ascribed to the difference in
(the direction of) current ﬂow rather than membrane voltage.
In sharp contrast to the ﬁndings at pH 8.4, the inhibitory
effect of FBM does not show any ﬂow dependence at pH 7.4
(Fig. 4, D–F), well consistent with the foregoing proposal
that FBM is chieﬂy a gating modiﬁer rather than a pore
blocker at the physiological pH (5). We therefore conclude
that FBM is an opportunistic pore blocker of the NMDA
channel, with its pore-blocking effect effectively modulated
by external proton (see Discussion for more details).
The inhibitory effect of FBM on NMDA currents
is antagonized by external but not internal Na1
at pH 8.4
If FBM blocks the NMDA channel pore at pH 8.4, then the
other travelers (e.g., Na1 ions) of the pore may interfere with
the action of FBM. Fig. 5, A and B, shows that the inhibitory
effect of FBM is signiﬁcantly reduced when external Na1 is
increased from 25 to 750 mM. However, the inhibition
remains unchanged when the internal Na1 concentration is
increased from 75 to 450 mM (Fig. 5 C). These ﬁndings
suggest that FBM blocks the NMDA channel pore from the
outside, and that the FBM binding site probably is located
quite externally in the pore (see Discussion). The effect of
external Na1 on FBM inhibition can be quantitatively de-
scribed by the following equation,
FIGURE 3 The differential effects of FBM on the current elicited by low
concentrations of NMDA between pH 7.4 and 8.4 could be abolished by
point mutations in M3c. (A) NMDA currents obtained from oocytes
coexpressing either the wild-type or mutant NR1 and wild-type NR2B
subunits were elicited by application of 6 mMNMDA plus 10 mM glycine in
the absence and presence of 300 mMFBM. The bars above the current traces
indicate application of the agonists (NMDA and glycine; open bar) and
FBM (solid bar). It is evident that FBM enhances the small current at pH 7.4
but not at pH 8.4 in the wild-type channel (131% vs. 98%). In contrast, FBM
enhances the current both at pH 7.4 and 8.4 in the A653C mutant channel
(128% vs. 129%). The dashed lines indicate zero current level. Because of
the limitation of perfusion speed in the oocyte preparation (oocytes are much
larger than native neurons), NMDA currents observed in oocytes are mostly
steady-state currents (including both open and desensitized NMDA
channels), roughly equivalent to the late sustained (not early peak) currents
observed in native neurons (Fig. 1 A). (B) Cumulative results are obtained
with the same experimental protocol described in panel A (n ¼ 4–6 for each
different channel). The relative current is deﬁned by the ratio between the
amplitude of the steady-state currents elicited by 6 mM NMDA pulse in the
presence and absence of 300 mMFBM in the same oocyte. The ratio of FBM
effects on NMDA currents at pH 7.4/pH 8.4 is then given by the ratio
between the relative current at pH 7.4 and 8.4. Positions marked with an
asterisk (*) are the previously reported probable proton-modulation sites
(23).
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Iexp ¼ Imin1 ððImax  IminÞ=ð11 ðKd=½Na1 ÞÞÞ; (1)
where Iexp, Imin, Imax, [Na
1], and Kd denote the experimental
current, the minimum current, the maximum current, the
external Na1 concentration, and the dissociation constant of
Na1 binding to the site affecting FBM inhibition, respec-
tively. The best ﬁts with Eq. 1 to the data points in Fig. 5 B
give very similar apparent Kd values of 258 and 275 mM for
the peak and sustained currents, respectively.
FBM has no effect on NMDA currents if
applied internally
So far we have applied FBM to the cell from the external
side. However, the uncharged form of FBM might cross the
cell membrane easily. Because there is no continuous and
rapid wash of the intracellular space, the FBM concentration
in the very small intracellular space may build up or even
become as high as that in the external solution. Therefore,
one cannot tell whether the externally applied FBM inhibits
the NMDA channel from the outside or from the inside based
on the previous experiments. Taking advantage of the rapid
and continuous solution change of the extracellular space in
the experimental system, we examined the effect of internal
FBM by adding 1 mM FBM to the pipette solution (Fig. 6).
Under such circumstances the FBM crossing the membrane
and reaching the outside would be quickly washed away, and
thus the internally applied FBM should not build up any
signiﬁcant concentration in the external solution. The NMDA
currents do not signiﬁcantly decrease throughout the exper-
iments (up to;25 min), and the current amplitude is always
comparable to those observed with FBM-free internal
solution (Fig. 6 A). Moreover, the inhibition induced by
300 mM external FBM is very similar no matter whether the
internal solution contains 1 mM FBM or not, conﬁrming that
the NMDA current observed in the presence of 1 mM
internal FBM is not a residual current already under sig-
niﬁcant inhibition (Fig. 6, B and C). These results, along with
FIGURE 4 The inhibitory effect of FBM on NMDA
currents is ﬂow-dependent at pH 8.4 but not at pH 7.4. (A)
Current-voltage (I–V) plots of the NMDA channel from a
representative cell. The currents activated by the applica-
tion of 1mM NMDA and 0.3 mM glycine in the absence
(control) and presence of 300 mM or 1 mM FBM at
extracellular pH 8.4. Both the external and internal
solutions contained 150 mM Na1. The peak NMDA
currents are measured at holding potentials from 70 to
170 mV and normalized to the amplitude of control peak
current measured at 70 mV in the same cell. I–V
relationships of four negative holding potentials (70,
50, 30, and 10 mV) are ﬁtted with linear regression
functions crossing the zero point. The solid, dashed, and
dotted lines are for the control, 300 mM, and 1 mM FBM
conditions, respectively. It is evident that the NMDA
current in 300 mM and 1 mM FBM are off the ﬁtting lines
at all positive holding potentials (110 to 170 mV),
illustrating the differential inhibitory effect of FBM
between inward and outward currents. (B,C) Cumulative
results are obtained from seven cells with the same
experimental protocol described in panel A. The percent
block (inhibition) of FBM on the peak NMDA current at
four holding potentials is summarized. The inhibitory
effect of FBM is essentially the same at 30 and 70 mV
(both inward currents, p . 0.05, n ¼ 7) and also the same
at130 and170 mV (both outward currents, p. 0.05, n¼
7), but evidently different between 30 (or 70) mV and
130 (or170) mV (p, 0.001, n ¼ 7). (D) I–V plots of the
NMDA channel from a representative cell were docu-
mented with the same experimental protocol as that in
panel A, but here the extracellular pH was 7.4. In sharp
contrast to the ﬁndings at pH 8.4, at pH 7.4 all data points
at positive holding potentials stay on the ﬁtting lines
deﬁned by the data points obtained at negative potentials.
(E,F) Cumulative results are obtained from ﬁve cells with
the same experimental protocol described in panel D. The
percent block of FBM on the current at four holding
potentials is shown. No signiﬁcant differences are noted
among these four holding potentials (p . 0.05, n ¼ 5).
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the ﬁnding that the inhibitory effect of FBM on NMDA cur-
rents is antagonized by external but not internal Na1 (Fig. 5),
strongly indicate that FBM binds to the NMDA channel pore
from the outside rather than from the inside.
FBM binds to the NMDA channel via a
one-to-one binding stoichiometry
Given the very similar apparent afﬁnities of FBM to the
NMDA channel at pH 7.4 and 8.4 (IC50 ¼ 0.71 and 0.64
mM, respectively; Fig. 1 E), the difference in binding energy
between FBM binding to the channel at pH 7.4 and 8.4 is
only ;0.1 RT (product of gas constant and absolute tem-
perature). This result may imply that there is only a relatively
small conformational change in the FBM binding site itself
when the extracellular pH is changed from 7.4 to 8.4. To
elucidate the molecular basis underlying this apparently
small conformational change, we further examined the
kinetics of FBM binding to and unbinding from the activated
NMDA channel in detail at extracellular pH 8.4. Fig. 7 A
FIGURE 5 The inhibitory effect of FBM on NMDA currents is dependent
on external but not internal Na1 at pH 8.4. (A) NMDA currents were elicited
by application of 1 mM NMDA and 0.3 mM glycine in the absence (control)
and presence of 300 mMFBM. At extracellular pH 8.4, the internal Na1was
ﬁxed at 150 mM, but the external Na1 was increased from 25 to 750 mM. It
is evident that the inhibitory effects of FBM on both peak and sustained
currents decrease with increased external Na1. The dashed line indicates
zero current level. (B) Cumulative results are obtained from seven cells with
the same experimental protocol described in panel A. The relative current is
deﬁned by the ratio between the amplitude of the currents elicited by 1 mM
NMDA pulse in FBM-containing and FBM-free external solutions in the
same cell, and is plotted against the concentration of external Na1. The lines
are the best ﬁts of the form: relative current¼ 0.691(0.31/(11(258/[Na1])))
and 0.631(0.37/(11(275/[Na1]))) for the peak and sustained currents,
respectively (see Eq. 1 in Results, where [Na1] denotes the Na1
concentration in mM). (C) Cumulative results are obtained from 12 cells
with the same experimental protocol described in panel A, but here the
internal Na1 was increased from 75 to 450 mM with the external Na1 ﬁxed
at 150 mM. The relative peak currents are 0.776 0.02, 0.766 0.01, 0.796
0.02, and 0.78 6 0.03 for 75, 150, 300, and 450 mM internal Na1,
respectively. The relative sustained currents are 0.71 6 0.02, 0.70 6 0.03,
0.71 6 0.03, and 0.72 6 0.03 for 75, 150, 300, and 450 mM internal Na1,
respectively.
FIGURE 6 Internal FBM has no inhibitory effect on NMDA currents. (A)
Every 1 min, NMDA currents were recorded with the same experimental
protocol as that in Fig. 1 A (at extracellular pH 8.4), but here the internal
solution contained 1 mM FBM. The numbers above the sweeps indicate
the recording time after establishment of the whole-cell conﬁguration. Note
the lack of signiﬁcant reduction of the NMDA current throughout the
experiment (up to ;25 min). The dashed line indicates zero current level.
(B) For comparison, 300 mM external FBM always signiﬁcantly inhibits the
NMDA current (the currents were also obtained 25 min after establishment
of the whole-cell conﬁguration). (C) With 1 mM internal FBM, the relative
peak and sustained currents in 300 mM external FBM (normalized to that in
zero external FBM) are 0.75 6 0.02, and 0.686 0.02, respectively (n ¼ 5).
For comparison, the relative peak and sustained currents with no FBM added
to the inside are 0.76 6 0.02, and 0.70 6 0.02, respectively (data from
Fig. 1 B).
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demonstrates the kinetics of development of and recovery
from inhibition by 100 or 1000mMFBM. It is evident that the
kinetics of development of inhibition are FBM concentration-
dependent, whereas the kinetics of recovery from inhibition
are not. Fig. 7 B shows a linear correlation between the
binding rates (inverses of the binding time constants) and
FBM concentrations, indicating that FBM interacts with the
NMDA channel via a one-to-one binding process (i.e., a
simple bimolecular reaction) and a macroscopic binding rate
constant of 4.4 3 104 M1 s1. The y-intercept of the linear
regression ﬁt to the macroscopic binding rate data in Fig. 7 B
is;3.9 s1, which is very much consistent with the inverses
of current relaxation (unbinding rate) time constants (;3.7
s1), a value evidently independent of FBM concentrations.
From the binding and unbinding rate constants, an apparent
dissociation constant of ;90 mM could be calculated for
FBM binding to the steady-state activated NMDA channels
(including both open and desensitized channels, as it is
difﬁcult to completely separate these two states with our
experimental approaches here). A dissociation constant of
;90 mM is well within the range of previously reported
dissociation constants of FBM to the open and desensitized
NMDA channels (;110 and ;55 mM, respectively) at pH
7.4 (5). Also, the kinetics of FBM binding to and unbinding
from the activated channels at pH 8.4 are essentially the same
as our previous reports (4.63 104 M1 s1 and 3.1–3.5 s1,
respectively) obtained at pH 7.4 (11). These ﬁndings, to-
gether with the very close IC50 values of FBM, are consistent
with the idea that the FBM binding site of the NMDA
channel undergoes only a small conformational change when
the extracellular pH is changed from 7.4 to 8.4.
External Na1 modulates the rate of FBM binding
to but not the rate of FBM unbinding from the
NMDA channel at pH 8.4
Fig. 7, C and D, further shows that the binding rates of 300
mM FBM to the activated NMDA channel are reduced when
external Na1 is increased from 50 to 450 mM (p , 0.05,
n ¼ 8, Fig. 7 C). Most interestingly, the unbinding rates are
relatively unaltered with increasing concentrations of exter-
nal Na1 (p . 0.05, n ¼ 8, Fig. 7 D). These intriguing
ﬁndings are consistent with the foregoing view that the
inhibition of NMDA currents by FBM is reduced in high
FIGURE 7 The kinetics of FBM binding to the activated
NMDA channel are linearly correlated with the FBM
concentration at pH 8.4. (A) The kinetics of development of
inhibition (left panel) and recovery from inhibition (right
panel) of the steady-state inward NMDA (1 mM) currents
were studied by fast application and removal of FBM with
Theta glass tubes at extracellular pH 8.4. (Left) The decay
phase of the current after application of FBM can be
reasonably ﬁtted with single-exponential functions, giving
macroscopic binding time constants of 115 and 22 ms for
100 and 1000 mM FBM, respectively. (Right) The
increment phase of the current after washoff of FBM can
be reasonably ﬁtted with single-exponential functions,
giving unbinding time constants of 287 and 295 ms for 100
and 1000 mM FBM, respectively. To avoid the effect from
incomplete solution change, the ﬁtting range is carefully
selected after a 10-ms delay in the decay or increment
phase of the current trace. The dashed lines indicate zero
current level. (B) Cumulative results are obtained from six
cells with the experiments described in panel A. The
binding and unbinding rates are obtained from the inverses
of the foregoing time constants and plotted against the
FBM concentration. The lines are linear regression ﬁts to
the mean values of the binding and unbinding rates,
respectively. For the binding rates, the slope and intercept
are 4.4 3 104 M1 s1 and 3.9 s1, respectively. For the
unbinding rates, the intercept is 3.7 s1 and the slope is
essentially zero (i.e., a horizontal line indicating that the
unbinding rates are unrelated to the FBM concentration).
(C,D) Cumulative results are obtained from eight cells with
300 mM FBM using the same experimental protocol
described in panel A. Here the internal Na1 was ﬁxed at
150 mM, but the external Na1 was increased from 50 to
450 mM. The binding rates are 26.96 1.1, 20.06 0.8, and
15.86 0.6 s1 for 50, 150, and 450 mM external Na1, respectively (C). The unbinding rates are 3.86 0.3, 3.76 0.2, and 3.96 0.2 s1 for 50, 150, and 450
mM external Na1, respectively (D). *p , 0.05, compared with the data of 150 mM external Na1.
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external Na1 in Fig. 5 B. It also implies that external Na1
and FBM may compete for a binding site located at the ex-
ternal pore mouth. Moreover, the fact that only the binding
but not the unbinding rates of FBM are affected by external
Na1 would suggest that this Na1 binding site is practically
the most external (outmost) ionic site in the NMDA channel
pore (see Discussion). The apparent afﬁnity (dissociation
constant) of Na1 to this outmost ionic site is ;260 mM
(Fig. 5 B), indicating that the occupancy of this site is not
negligible in physiological concentrations (;150 mM) of
extracellular Na1.
The afﬁnity of Na1 to the outmost ionic site in the
NMDA channel pore is not signiﬁcantly altered
by a change of extracellular pH from 8.4 to 7.4
We have shown that Na1 and FBM compete for a common
superﬁcial binding site at the external pore mouth of the
NMDA channel at pH 8.4. Because there is probably only a
small conformational change in the FBM binding site
between pH 8.4 and 7.4, it is interesting to see whether the
afﬁnity of Na1 to the outmost ionic site is altered by a
change of extracellular pH from 8.4 to 7.4. Fig. 8 A shows
that FBM has little inhibition on the peak currents but much
more prominent inhibitory effect on the sustained currents at
pH 7.4 (i.e., use-dependent inhibition), and the inhibition is
decreased when the external Na1 concentration is increased
from 25 to 750 mM. Again, the inhibitory effect of FBM
remains unchanged if internal Na1 is increased from 75 to
450 mM at pH 7.4 (Fig. 8 B). These ﬁndings suggest that the
gating-modiﬁcation effect of FBM on NMDA channels at
pH 7.4 is also antagonized by external but not internal Na1,
consistent with the idea that the FBM binding site is located
at the external pore mouth, directly facing the external rather
than the internal solution. Because we have kept the
osmolarity roughly equal on both sides of the membrane
with the addition of sucrose (see Materials and Methods), the
lack of effect of increased internal Na1 on FBM inhibition at
both pH 8.4 and 7.4 (Figs. 5 C and 8 B) would argue against
the antagonizing effect of increased external Na1 on FBM
inhibition being ascribable to some nonspeciﬁc effects (e.g.,
different osmolarities) of the solutions. Quantitatively, the
apparent Kd of Na
1 binding to the outmost ionic site at pH
7.4 could also be calculated using Eq. 1, giving a value of
262 mM (Fig. 8 A). This Kd value of 262 mM at pH 7.4 is
very similar to those obtained at pH 8.4 (258 and 275 mM,
Fig. 5 B), indicating that FBM binds to the same site in the
NMDA channel at pH 7.4 (acting as a gating modiﬁer but not
a pore blocker) and at pH 8.4 (showing an evident pore-
blocking effect). The binding site, however, would undergo
delicate but functionally important conformational changes
upon the one pH unit change from 7.4 to 8.4. In this regard, it
is interesting to note that extracellular Na1 ions signiﬁcantly
antagonize the inhibitory effect of FBM on NMDA currents
at both pH 8.4 and 7.4 (Figs. 5 and 8). By contrast, the Na1
ions ﬂowing through the pore signiﬁcantly attenuate the
inhibitory effect of FBM only at pH 8.4 but not at pH 7.4
(Fig. 4). The FBM binding site thus should be located in the
ion conduction pathway, and at a position very close to the
extracellular rather than the intracellular milieu (see Discus-
sion).
FIGURE 8 The inhibitory effect of FBM on NMDA currents at pH 7.4 is
also dependent on external but not internal Na1. (A) Cumulative results are
obtained from ﬁve cells with the same experimental protocol described in
Fig. 5 B, but here the extracellular pH was 7.4. The relative peak currents are
0.88 6 0.02, 0.89 6 0.01, 0.90 6 0.01, 0.92 6 0.02, 0.93 6 0.02, 0.95 6
0.01, and 0.956 0.03 for 25, 75, 150, 300, 450, 600, and 750 mM external
Na1, respectively. The relative sustained currents are 0.67 6 0.02, 0.68 6
0.01, 0.736 0.02, 0.786 0.02, 0.836 0.03, 0.866 0.01, and 0.866 0.03
for 25, 75, 150, 300, 450, 600, and 750 mM external Na1, respectively. For
the relative sustained currents, the line is the best ﬁt of the form: relative
current ¼ 0.671(0.21/(11(262/[Na1]))), where [Na1] denotes the Na1
concentration in mM. (B) Cumulative results are obtained from 12 cells with
the same experimental protocol described in Fig. 5 C, but here the
extracellular pH was 7.4. The relative peak currents are 0.916 0.02, 0.906
0.01, 0.91 6 0.01, and 0.91 6 0.03 for 75, 150, 300, and 450 mM internal
Na1, respectively. The relative sustained currents are 0.73 6 0.02, 0.75 6
0.01, 0.72 6 0.03, and 0.73 6 0.03 for 75, 150, 300, and 450 mM internal
Na1, respectively.
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DISCUSSION
FBM acts as an opportunistic NMDA channel
pore blocker modulated by extracellular proton
Our previous study (5) has demonstrated that FBM is a use-
dependent gating modiﬁer of the NMDA channel at physio-
logical pH (i.e., pH 7.4). At its therapeutic concentrations
(50–300 mM), FBM effectively enhances NMDA channel
activation and especially the desensitization processes. In
this study, we demonstrated that although FBM is an
effective gating modiﬁer rather than a pore blocker at pH 7.4,
it is turned into an evident pore blocker at pH 8.4. The similar
inhibition of the peak current and the late sustained (steady-
state) current at pH 8.4 (Fig. 1) further implies that FBM
could bind to the closed state of the NMDA channel and then
decrease ionic ﬂow upon channel opening. These ﬁndings
suggest that FBM is a pore blocker, but not an open channel
blocker, which can only bind to and block the pore after
channel opening. Although native neurons express several
subtypes of NMDA channels with different desensitization
kinetics properties (28) and different sensitivity to FBM
(4,16). The NMDA channels in neonatal rat hippocampal
neurons (that we used in this study) are mainly composed of
NR1-2B subunits (29). Also, the very similar ﬁndings that
the differential effects of FBM on NMDA currents between
pH 7.4 and 8.4 are observed in both native (Fig. 2) and re-
combinant NR1-2B (Fig. 3 A) NMDA channels also indicate
a genuine interaction between proton and FBM on the NMDA
channel protein. Moreover, the apparent afﬁnity (IC50) of
FBM in this study (0.71 and 0.64 mM at pH 7.4 and 8.4,
respectively; Fig. 1 E) is very similar to that observed in
recombinant NR1-2B NMDA channels (e.g., 0.93 and 0.95
mM at pH 7.4 and 8.3, respectively in (4); 0.52 mM at pH 7.4
in (16)). The signiﬁcant different effects of FBM between pH
7.4 and 8.4 (Figs. 1–4) thus may be viewed as ﬁndings
mainly from the NR1-2B NMDA channels, and cannot be
ascribed to a heterogeneous population of the NMDA channel
in native neurons.
The FBM binding site is located at the external
pore mouth and shows a delicate proton-modulated
local conformational change
We show that the rate of FBM binding to the activated
NMDA channel is linearly correlated with the FBM
concentration at pH 8.4 (Fig. 7 B). FBM thus very likely
binds to the NMDA channel via a one-to-one binding stoi-
chiometry (i.e., a simple bimolecular reaction) with a binding
rate constant of 4.43 104 M1 s1 at pH 8.4. These ﬁndings
are qualitatively and quantitatively very similar to those
obtained at pH 7.4 (11). The striking similarity implies that
FBM binds to the same site in the NMDA channel at pH 7.4
and 8.4. Also, this binding site itself probably undergoes
only a small conformational change to make FBM a partial
pore blocker when the extracellular pH is increased from 7.4
to 8.4 (and probably also in some other experimental
conditions, e.g., (6,7)). This intriguing opportunistic pore
blocking effect would locate the FBM binding site to a pore
region of critical dimensions, most likely the junction of a
widened and a narrow part of the ion conduction pathway (so
that its pore-blocking effect could be dramatically altered by
a small local conformational change). Also, only externally
but not internally applied FBM could signiﬁcantly inhibits
NMDA currents (Fig. 6), and only external but not internal
Na1 ions show an antagonistic effect on FBM binding (Figs.
5 and 8). The FBM binding site thus is very likely located at
the external pore mouth of the NMDA channel pore (prob-
ably the inner end of the external vestibule and coincide with
the outmost ionic site; see below and Fig. 9).
FIGURE 9 A schematic model describes the extracellular proton-modulated
pore-blocking effect of FBM on the NMDA channel. (A) The chemical
formula of FBM is shown in the left panel. The phenyl group of FBM is
shown by a black circle, and the symmetrical propanediol dicarbamate group
is shown by a hatched rectangle in the right panel. (B) A presumable proton
sensor (open semicircle) is depicted at the external vestibule of the NMDA
channel protein. The two light shaded areas in the channel protein mark the
location of the binding ligands for FBM. At extracellular pH 8.4, FBM binds
to the light shaded areas in the external pore mouth to compromise the ion
conduction pathway and partially block ionic ﬂow (left panel). When the
proton sensor is more occupied at pH 7.4, the external pore mouth undergoes
a delicate local conformational change and the ion conduction pathway of
the FBM-bound channel may therefore remain patent to the permeating Na1
ions (right panel). The molecular interaction between FBM and its binding
ligands, however, is similar at pH 7.4 and 8.4. The FBM binding site
presumably is conceivably located at a pore region of critical dimensions,
most likely the junction of a widened and a narrow part (presumably the
junction of the external vestibule and the single-ﬁle region of the pore), so
that FBM could behave as an opportunistic pore blocker modulated by the
delicate local conformational change caused by extracellular proton binding.
On the other hand, the outmost ionic (Na1) site (shaded semicircle) of the
NMDA channel pore and the FBM binding site probably overlap each other.
Because this ionic site essentially faces the external solution, FBM binding
would be affected by only external but not internal Na1.
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FBM may only partially block the NMDA channel at
extracellular pH 8.4
It is very intriguing that we have an IC50 value of ;0.6 mM
(Fig. 1 E), but a much smaller value (;90 mM) for the
dissociation constant of FBM to the activated (open and
desensitized) NMDA channels in Fig. 7 B. This ﬁnding
would suggest that although FBM may affect current ﬂow
through the NMDA channel pore at pH 8.4, the inhibitory
effect of FBM on NMDA currents remains partly or even
largely ascribable to gating modiﬁcation. In other words,
FBM does not seem to block the NMDA channel pore
completely at pH 8.4. A rough estimate of the extent of pore
blocker at pH 8.4 may be derived from the ﬁndings in Fig. 1.
The relative currents at pH 8.4 in Fig. 1 B are ;10%
(sustained currents) to ;20% (peak currents) smaller than
those at pH 7.4 and 6.4. Assuming that 300 mM FBM could
occupy most of the activated NMDA channels (the apparent
dissociation constants of FBM binding to the open and
desensitized NMDA channels are ;110 and ;55 mM,
respectively; (5)), the 10–20% further decrease in relative
currents would suggest a decrease in NMDA channel con-
ductance by only 10–20% in case of roughly similar gating
modiﬁcation between pH 7.4 and 8.4. This very modest
pore-blocking effect, and the usual existence of subcon-
ductance levels in NMDA channels, may preclude an
effective and straightforward demonstration of the pore-
blocking effect of FBM at pH 8.4 based on the single-
channel recordings. The very modest (10–20%) decrease in
NMDA channel conductance may also explain the nearly
identical concentration-response curves of FBM at pH 7.4
and 8.4 in Fig. 1 E, and the relatively abrupt change of the
relative currents or activation speeds from 1.3 to 1.5 (pH 7.4)
to 1.00–1.05 at pH 8.4 in Fig. 2, C and D. The development
of the small pore-blocking effect of FBM at pH 8.4 is also
consistent with the idea that the FBM binding site may only
undergo a small (but functionally signiﬁcant) local confor-
mational change upon the one pH unit change from 7.4 to 8.4
(see also Fig. 9).
The FBM binding site overlaps the outmost ionic
site in the NMDA channel pore
We have argued that the FBM binding site is very likely
located at the junction of a widened and a narrow part at the
external pore mouth of the NMDA channel, and overlaps
with a Na1 binding site. Most interestingly, the antagonistic
effect of external Na1 on FBM binding is characterized by
decreased binding rates but essentially unchanged unbinding
rates of FBM with increasing concentrations of external Na1
(Fig. 7, C and D). This ﬁnding indicates that this overlapping
Na1 site is practically the most external (outmost) ionic site
in the NMDA channel pore. In other words, if there was
another ionic binding site which could be signiﬁcantly
occupied with ;150 mM Na1 and was located external to
the FBM binding site in the pore, the unbinding rate of FBM
would have been signiﬁcantly decreased with increasing
concentrations of external Na1 in Fig. 7 D. Functionally
speaking, this outmost ionic site most likely is located in the
widened vestibule external to the narrow constriction or
presumably the selectivity ﬁlter of the pore, and thus is ef-
fectively occupied by only external rather than internal Na1
(which readily dissipates into the external milieu when
permeating to this point). The apparent afﬁnity of Na1 to this
outmost ionic site is not high (Kd ¼;260 mM, Figs. 5 B and
8 A). However, it remains a possibility that Na1 binding
to this site may play a role in the molecular operation of
the NMDA channel in physiological conditions, which usu-
ally dictate ;150 mM Na1 in the extracellular ﬂuid in
mammals.
Extracellular proton, Na1, FBM, and NMDA
channel gating may have an orchestrating
effect on the external pore mouth
Extracellular proton is an effective modulator of the NMDA
channel, and there could be a tonic inhibition of NMDA
currents by ;50% at physiological pH (17–20). Banke et al.
further reported that submicromolar extracellular proton
effectively inhibited NMDA currents by trapping the channel
in a nonconducting state, and thus there is a tight coupling
between the proton sensor and channel gating (30). Using
site-directed mutagenesis and homology modeling, Low
et al. reported that the residues clustered in both the
extracellular (or C-terminal) end of the second transmem-
brane (M3c) domain and the adjacent linker to the ligand-
binding domain S2 (M3-S2 linker) of the NR1 and NR2
subunits signiﬁcantly modulated the proton sensitivity of the
NMDA channel (23). Interestingly, we also demonstrate that
the differential effects of FBM on NMDA currents between
pH 7.4 and 8.4 are abolished by point mutations (in M3c and
M3-S2 linker of NR1), which exactly coincide with the
probable proton sensor sites reported by Low et al. (23). On
the other hand, the M3c domain probably also forms the
main part of the external vestibule of the NMDA channel
pore (31,32), and could be critically related to channel gating
(23,33–35). Extracellular proton binding thus may delicately
but signiﬁcantly alter the local conformation of (the inner
end of) the external vestibule, which harbors important drug
(e.g., FBM) binding sites and the outmost ionic (e.g., Na1)
site of the NMDA channel pore (Fig. 9). The picture that the
outmost ionic site overlaps with the FBM binding site would
also be consistent with the previous view that there may be a
strong coupling between permeation and gating in the
NMDA channel (36,37). The external pore mouth thus very
likely plays an essential role in the molecular physiology
(e.g., channel gating, ion permeation, and proton modula-
tion) and pharmacology (e.g., gating modiﬁers such as FBM)
of the NMDA channel. In this regard, FBM may not only be
a clinically important anticonvulsant, but also serve as a
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powerful probe to study the molecular operation and
structural correlates of the NMDA channel.
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